Want to see SBRA full AI Analyst Report?
SBRA Stock Chart & Stats
$20.68
$0.38(2.29%)
At close: 4:00 PM EST
$20.68
$0.38(2.29%)
Day’s Range― - ―
52-Week Range$17.17 - $21.28
Previous CloseN/A
Volume723.92K
Average Volume (3M)3.42M
Market Cap
$5.01B
Enterprise Value$7.12B
Total Cash (Recent Filing)$123.45M
Total Debt (Recent Filing)$2.69B
Price to Earnings (P/E)30.4
Beta0.16
Next Earnings
Aug 10, 2026EPS Estimate
0.17Next Dividend Ex-DateN/A
Dividend Yield6.47%
Share Statistics
EPS (TTM)0.64
Shares Outstanding252,190,100
10 Day Avg. Volume3,270,921
30 Day Avg. Volume3,418,224
Financial Highlights & Ratios
PEG Ratio1.60
Price to Book (P/B)1.62
Price to Sales (P/S)5.90
P/FCF Ratio13.11
Enterprise Value/Market Cap1.42
Enterprise Value/Revenue8.76
Enterprise Value/Gross Profit13.80
Enterprise Value/Ebitda15.27
Forecast
1Y Price Target
$21.19Price Target Upside2.48% Upside
Rating ConsensusHold
Number of Analyst Covering9
EPS Forecast (FY)0.67
Revenue Forecast (FY)$893.49M
Bulls Say, Bears Say
Bulls Say
Cash Flow ResilienceNormalized funds available for distribution met analyst expectations after excluding a small related capital expenditure, indicating resilient distributable cash generation.
Growth Pipeline FundingInvestment activity is accelerating with a sizable, largely pre-funded pipeline, enabling disciplined expansion without immediate capital strain.
Senior Housing Operating PerformanceSame-store net operating income for the senior housing portfolio showed solid growth alongside improving occupancy, supporting steady operating cash flow and demographic-driven demand.
Bears Say
Acquisition Strategy And Organic Growth ConcernsThe SHOP acquisition strategy and platform lack clear differentiation while organic growth in SHOP trails peers, raising concerns about long-term competitive positioning.
Cost Of Capital PressureA higher cost of capital reduces accretion from new investments, constraining return potential relative to lower-cost competitors.
Maturing Loan And Operator Credit RiskAnalysts are seeking more clarity on expectations for a large maturing loan and on the operating partner's financial health, creating refinancing and partnership risk.
Sabra Healthcare REIT News
SBRA FAQ
What was Sabra Healthcare Reit’s price range in the past 12 months?
Sabra Healthcare Reit lowest stock price was $17.16 and its highest was $21.28 in the past 12 months.
What is Sabra Healthcare Reit’s market cap?
Sabra Healthcare Reit’s market cap is $5.01B.
When is Sabra Healthcare Reit’s upcoming earnings report date?
Sabra Healthcare Reit’s upcoming earnings report date is Aug 10, 2026 which is in 30 days.
How were Sabra Healthcare Reit’s earnings last quarter?
Sabra Healthcare Reit released its earnings results on Apr 29, 2026. The company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.161 by -$0.001.
Is Sabra Healthcare Reit overvalued?
According to Wall Street analysts Sabra Healthcare Reit’s price is currently Undervalued.
Does Sabra Healthcare Reit pay dividends?
Sabra Healthcare Reit pays a Quarterly dividend of $0.3 which represents an annual dividend yield of 6.47%. See more information on Sabra Healthcare Reit dividends here
What is Sabra Healthcare Reit’s EPS estimate?
Sabra Healthcare Reit’s EPS estimate is 0.17.
How many shares outstanding does Sabra Healthcare Reit have?
Sabra Healthcare Reit has 252,190,100 shares outstanding.
What happened to Sabra Healthcare Reit’s price movement after its last earnings report?
Sabra Healthcare Reit reported an EPS of $0.16 in its last earnings report, missing expectations of $0.161. Following the earnings report the stock price went up 1.52%.
Which hedge fund is a major shareholder of Sabra Healthcare Reit?
Currently, no hedge funds are holding shares in SBRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sabra Healthcare REIT Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$21.19 (2.48% Upside)
$21.19 (2.48% Upside)
Blogger Sentiment
Bullish
SBRA Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 111.6K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
Last 30 Days ▼ 2.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
14.31%
12-Months-Change
Fundamentals
Return on Equity
5.61%
Trailing 12-Months
Asset Growth
6.84%
Trailing 12-Months
Company Description
Sabra Healthcare Reit
As of March 31, 2022, Sabra Health Care REIT, Inc. held a diverse investment portfolio. This largely comprised 416 income-generating real estate properties, which included: 279 skilled nursing and transitional care facilities; 59 senior living communities operating under lease agreements; 50 senior housing properties managed by external operators; 13 behavioral health centers; and 15 specialized hospitals and other healthcare sites. In addition to its real estate holdings, Sabra's portfolio also featured: a single asset earmarked for sale; one sales-type lease arrangement; a total of 16 loan receivables, consisting of two mortgage loans, one construction loan, and thirteen other debt instruments; seven preferred equity stakes; and an interest in one unconsolidated joint venture. Collectively, these 416 investment properties offered a capacity of 41,445 beds and residential units, geographically distributed across both the United States and Canada.
SBRA Company Deck
SBRA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong and accelerating SHOP deal flow and operating performance (notably robust same-store revenue, occupancy, RevPAR, and NOI growth), record private-pay concentration, healthy FFO/AFFO growth, solid liquidity, and disciplined capital use (forward equity locks). Key negatives are limited and include certain asset transitions (Holiday assets), legal/sale process for Landmark behavioral assets, a highly competitive skilled nursing acquisition market that limits SNF opportunities, modest increases in G&A and the reaffirmation of guidance (conservative stance) with a plan to reassess in Q2. On balance, the positive operating trends, material pipeline, and balance-sheet flexibility outweigh the risks and uncertainties discussed.View all SBRA earnings summariesSBRA Stock 12 Month Forecast
Average Price Target
$21.19
▲(2.48% Upside)
Technical Analysis
LTC Properties
―
National Health Investors
―
Omega Healthcare
―
―
Diversified Healthcare Trust
―
Ownership Overview
1.97% Insiders
27.65% Mutual Funds
0.50% Other Institutional Investors
36.29% Public Companies and
Individual Investors